Phase II study of erlotinib for chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum doublets

DH Lee, SW Kim, C Suh, YH Han, JS Lee - Cancer chemotherapy and …, 2011 - Springer
Purpose This phase II study evaluated efficacy of single-agent erlotinib for chemotherapy-
naïve patients with advanced/metastatic NSCLC who were ineligible for platinum doublets …
被引用次数：30 相关文章

[引用][C] Phase II study of erlotinib for chemotherapy-naïve patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum doublets

DAEHO LEE, SW KIM, C SUH… - Cancer …, 2011 - pascal-francis.inist.fr
Phase II study of erlotinib for chemotherapy-naïve patients with advanced or metastatic non-small
cell lung cancer who are ineligible for platinum doublets CNRS Inist Pascal-Francis CNRS …

Phase II study of erlotinib for chemotherapy-naïve patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum doublets.

D Lee, SW Kim, C Suh, Y Han… - Cancer Chemotherapy & …, 2011 - search.ebscohost.com
Purpose: This phase II study evaluated efficacy of single-agent erlotinib for chemotherapy-
naïve patients with advanced/metastatic NSCLC who were ineligible for platinum doublets …

Phase II study of erlotinib for chemotherapy-naïve patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum doublets.

DH Lee, SW Kim, C Suh, YH Han… - Cancer Chemotherapy …, 2010 - europepmc.org
Purpose This phase II study evaluated efficacy of single-agent erlotinib for chemotherapy-
naïve patients with advanced/metastatic NSCLC who were ineligible for platinum doublets …

Phase II study of erlotinib for chemotherapy-naïve patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum doublets

DH Lee, S Kim, C Suh, YH Han… - Cancer Chemotherapy …, 2011 - search.proquest.com
This phase II study evaluated efficacy of single-agent erlotinib for chemotherapy-naïve
patients with advanced/metastatic NSCLC who were ineligible for platinum doublets …

Phase II study of erlotinib for chemotherapy-naïve patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum doublets

DH Lee, SW Kim, C Suh, YH Han, JS Lee - Cancer Chemotherapy and …, 2011 - infona.pl
Purpose This phase II study evaluated efficacy of single-agent erlotinib for chemotherapy-
naïve patients with advanced/metastatic NSCLC who were ineligible for platinum doublets …

Phase II study of erlotinib for chemotherapy-naïve patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum doublets

DH Lee, SW Kim, C Suh, YH Han… - Cancer chemotherapy …, 2011 - pubmed.ncbi.nlm.nih.gov
Purpose This phase II study evaluated efficacy of single-agent erlotinib for chemotherapy-
naïve patients with advanced/metastatic NSCLC who were ineligible for platinum doublets …

[引用][C] Phase II study of erlotinib for chemotherapy-naïve patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum doublets

DH Lee, SW Kim, C Suh, YH Han, JS Lee - Cancer Chemotherapy and …, 2011 - Springer